MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...
2 天
Emirates News Agency on MSNAbu Dhabi to introduce standards for offerings beyond nurseries, schoolsOn the occasion of Emirati Children’s Day, the Abu Dhabi Early Childhood Authority (ECA) is announcing that it is designing ...
4 天
220 Triathlon on MSNBest indoor cycling shoes to buy in 2025Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...
Under Article 471 of the UAE Penal Code, neglecting or mistreating animals could result in fines of up to Dh5,000 Stay up to ...
A take-at-home tablet for multiple sclerosis (MS) is set to be more broadly rolled out on the NHS, potentially benefiting thousands of patients in England. The move will also “significantly free up ...
As the weeks go by, more and more Bond 2023 projects are underway. New surveillance cameras at Odessa High School have been installed and Permian High School is near completion. New Tech Odessa will ...
The escalating global plastics crisis, exemplified by the >31 million tons of PET production in 2019, necessitates efficient recycling strategies as ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...
"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.
A simple treatment algorithm to aid in the selection of appropriate DMTs reduces racial disparities in patients with ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果